Anshul Mangal and Tony Khoury of Project Farma weigh in on ways to address the cell and gene therapy skills gap in the US.

How can the NLRP3 inflammasome can be exploited to slow the decline associated with Alzheimer's disease?

Meet Ori Biotech’s Jason Foster. How did he transition to advanced therapy, and why did he end up in the UK?

A drug development journey with origins in the 1950s has finally reached its successful conclusion: a new treatment for lupus.

Four courageous marketer-knights weigh in on what it takes to tilt against the social media windmills of pharma’s digital content kingdom.

Charlie Badham of 4D Pharma tells us his approach to social media in an age of outrage and tonal mixups.

Mike Rea of IDEA Pharma speaks frankly on the mud fights, echo chambers, and risks at play in the virtual forums of social media in 2021.

Simple and efficient systems for continuous monitoring can make all the difference in developing innovative products.

Richard Wiens explains the importance of Cobalt-60 in the pharma industry – and why Nordion is a key player in the field

When it comes to delivering medicines to patients in need, choosing the right packaging partner can make all the difference.